Evoke Pharma Inc financial metrics

Professional SEC-based dashboard for profitability, financial health, and growth with transparent scoring logic. Latest period: Q3 2025.

Symbol
EVOK on Nasdaq
Location
Solana Beach, CA
Fiscal year end
31 December
Latest financial report
13 Nov 2025

Shareable Research Card

EVOK - Evoke Pharma Inc Financial Facts

EVOK - Evoke Pharma Inc has a source-backed company facts page for reviewing reported financial metrics, periods, and linked metric histories.

Start with the latest metric summary, then open metric histories or cross-company rankings to compare the same SEC-backed facts.

Context
Latest metrics period: Q3 2025
Latest reported value
Return On Equity -135%

Based on company facts extracted from SEC 10-Q/10-K XBRL filings where available. Open metric pages to inspect the reported history.

Open stable link Open latest 10-Q/10-K hub Which companies report the highest revenue?

Quick Takeaways

  • EVOK - Evoke Pharma Inc financial facts are built from SEC company filings data.
  • Latest metrics period on this page: Q3 2025.
  • Headline metric: Return On Equity -135%.

What Changed

  • Return On Equity YoY change: <span class="text-red-600">-63%</span>.
  • Most recent SEC facts end date: 06 Nov 2025.

Why This Matters

  • This gives a beginner-friendly first read before you inspect detailed formulas and metric tables.
  • Every metric card links to a deeper SEC-backed history page for verification.

Source Evidence

Based on latest 10-Q/10-K

Based on company facts extracted from SEC 10-Q/10-K XBRL filings where available. Open company facts to inspect the reported metric history.

See Original Filing

Latest SEC snapshot (2025-11-06) highlights Return On Equity -134.9%, Return On Assets -35.1%, and Operating Margin -36.0%.

Compare This Company Through SEC-backed Metrics

Use these links to compare EVOK - Evoke Pharma Inc against other SEC filers on the same metric, then verify the company history from the paired facts page.

Financial Quality Score

Transparent 0-100 scoring model based on profitability, financial health, and growth factors.

49.5/100

Caution Confidence high

Return On Equity

-135%

Metric score 0.0/100

Return On Assets

-35%

Metric score 0.0/100

Financial Health

Current Ratio
1.27x
Quick Ratio
1.22x
Debt to Equity
2.18x

Strengths

Current Ratio, Quick Ratio, and Revenues YoY

Watchpoints

Return On Equity, Return On Assets, and Operating Margin

Key metrics snapshot

Return On Equity

-135%

YoY: -63%

Industry median: -43% (n=675)

View history

Return On Assets

-35%

YoY: -40%

Industry median: -47% (n=673)

View history

Operating Margin

-36%

YoY: -47%

Industry median: -121% (n=298)

View history

Current Ratio

1.27x

YoY: -12%

Industry median: 3.39x (n=667)

View history

Quick Ratio

1.22x

YoY: -12%

Industry median: 1.51x (n=289)

View history

Debt-to-equity

2.18x

YoY: -54%

Industry median: 0.26x (n=530)

View history

Revenues YoY

67%

YoY:

Industry median: 7.3% (n=302)

View history

NetIncomeLoss YoY

19%

YoY:

Industry median: -0.93% (n=641)

View history

Profitability

Metric Latest value YoY change
Return On Equity -135% -63%
Return On Assets -35% -40%
Operating Margin -36% -47%

Financial Health

Metric Latest value YoY change
Current Ratio 1.27x -12%
Quick Ratio 1.22x -12%
Debt-to-equity 2.18x -54%

Growth

Metric Latest value YoY change
Revenues YoY 67%
NetIncomeLoss YoY 19%

Share Metrics

Metric Latest value YoY change
Entity Common Stock, Shares Outstanding 1,722,409 +16%
Common Stock, Shares, Outstanding 1,722,409 +92%
Common Stock, Value, Issued $172 +93%
Weighted Average Number of Shares Outstanding, Basic 2,557,408 +83%
Weighted Average Number of Shares Outstanding, Diluted 2,557,408 +83%

Additional Metrics

Metric Latest value YoY change
Revenue from Contract with Customer, Excluding Assessed Tax $14,424,652 +67%
Operating Income (Loss) $5,191,981 +12%
Earnings Per Share, Basic 0 +98%
Earnings Per Share, Diluted 0 +98%
Cash and Cash Equivalents, at Carrying Value $11,576,010 +2.1%
Inventory, Net $599,908 +22%
Other Assets, Current $33,708 -7.4%
Assets, Current $15,536,407 +11%
Operating Lease, Right-of-Use Asset $106,714
Other Assets, Noncurrent $6,312
Assets $15,649,433 +11%
Employee-related Liabilities, Current $770,915 +31%
Liabilities, Current $12,240,816 +25%
Operating Lease, Liability, Noncurrent $46,381
Liabilities $12,287,197 +26%
Retained Earnings (Accumulated Deficit) $132,824,994 -4.1%
Stockholders' Equity Attributable to Parent $3,362,236 -23%
Liabilities and Equity $15,649,433 +11%
Share-based Payment Arrangement, Noncash Expense $554,620 -30%
Common Stock, Shares Authorized 100,000,000 0%
Common Stock, Shares, Issued 1,722,409 +92%
Common Stock, Par or Stated Value Per Share 0 0%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents $11,576,010 +2.1%
Operating Lease, Liability $112,349
Lessee, Operating Lease, Liability, to be Paid $120,516
Operating Lease, Liability, Current $65,968
Lessee, Operating Lease, Liability, to be Paid, Year Two $20,551
Lessee, Operating Lease, Liability, to be Paid, Year One $80,207
Lessee, Operating Lease, Liability, Undiscounted Excess Amount $8,167
Preferred Stock, Shares Issued 0
Preferred Stock, Shares Authorized 5,000,000 0%
Operating Lease, Payments $70,803 -15%
Preferred Stock, Shares Outstanding 0
Interest Expense $500,001 -0.27%
Preferred Stock, Par or Stated Value Per Share 0 0%

How we score

This score is transparent and deterministic. We weight profitability, financial health, and growth metrics, then renormalize weights when SEC data is missing.

Metric Weight V1 threshold
ROIC205% to 20%
ROE158% to 25%
ROA102% to 10%
Operating Margin55% to 25%
Current Ratio121.0x to 2.0x
Quick Ratio80.8x to 1.5x
Debt to Equity100.3x to 2.0x (lower is better)
Revenue YoY10-10% to +20%
Net Income YoY10-10% to +20%

How Calculated (standard_v1)

Metrics are computed with a market-consensus convention designed for cross-portal comparability.

  • TTM Operating Income / TTM Revenues
  • Current Assets / Current Liabilities (latest instant quarter)
  • (Current Assets - Inventory) / Current Liabilities; fallback: (Cash+Short-Term Investments + Accounts Receivable) / Current Liabilities
  • Total Debt / Stockholders Equity (latest instant quarter; shared unit; freshest series)
  • TTM Net Income / Average Equity (current quarter + same quarter previous year) / 2
  • TTM Net Income / Average Assets (current quarter + same quarter previous year) / 2
  • TTM NOPAT / Average Invested Capital, where NOPAT=Operating Income*(1-tax rate), Invested Capital=Equity+Total Debt-Cash & ST Investments
  • TTM Revenues YoY
  • TTM Net Income YoY